Arlene M. Correa - Concepedia

Author

Arlene M. Correa

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

A CORREA, A Correa, A. Correa, A. M. Correa, A.M. Correa, Angélica María De Luque Correa, Antônio Carlos de Souza Correa, Arlene Correa, Arlene M Correa, Arlene M. Correa

321

Publications

13.6K

Citations

H-Index

102

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Thoracic Surgery Foundation Methodist Hospital Cornell University

About

Arlene M. Correa is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	91	6.5K
2	Health Sciences	16	19	1.7K
3	Public Health	2	2	366
4	Engineering	1	1	20
5	Nursing	1	1	20

Arlene M. Correa

175

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation Lucian R. Chirieac, Stephen G. Swisher, Jaffer A. Ajani, Cancer	2005	484
Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy Apar Pataer, Neda Kalhor, Arlene M. Correa, Journal of Thoracic Oncology Surgical OncologyNeoadjuvant ChemotherapyResected Lung CancerMedicineCancer Recurrence	2012	351
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients Ara A. Vaporciyan, Arlene M. Correa, David C. Rice, Journal of Thoracic and Cardiovascular Surgery Cardiothoracic SurgeryCardiovascular DiseasePatient SafetyOutcomes ResearchThoracic Surgery	2004	347
Endoscopic Ultrasound-Guided Fine Needle Aspiration and Multidetector Spiral CT in the Diagnosis of Pancreatic Cancer Banke Agarwal, Emad Abu-Hamda, Kimber L. Molke, The American Journal of Gastroenterology	2004	326
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery Joe Y. Chang, Reza J. Mehran, Lei Feng, The Lancet Oncology Surgical OncologyRadiation TherapyMedicineBronchial NeoplasmThoracic Surgery	2021	304
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy Stephen G. Swisher, Paula Wynn, Joe B. Putnam, Journal of Thoracic and Cardiovascular Surgery Neuro-oncologyEsophagusEsophageal CancerRadiation TherapySalvage Esophagectomy	2002	269
The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer Shumei Song, Soichiro Honjo, Jiankang Jin, Clinical Cancer Research	2015	267
2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma Stephen G. Swisher, Jeremy Erasmus, Mary S. Maish, Cancer	2004	265
Treatment Outcomes of Resected Esophageal Cancer Wayne L. Hofstetter, Stephen G. Swisher, Arlene M. Correa, Annals of Surgery	2002	259
Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, Craig Stevens, Arlene M. Correa, The Annals of Thoracic Surgery Surgical OncologyMalignant Pleural MesotheliomaIntensity-modulated Radiation TherapyRadiation TherapyMedicine	2007	217

Page 1